Ohcanbohtosat - Jonel Trebicka

Aiddostahte ozu
  1. 1
    Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy

    Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy Dahkki Yasuko Iwakiri, Jonel Trebicka

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Etiology and Complications of Portal Vein Thrombosis

    Etiology and Complications of Portal Vein Thrombosis Dahkki Jonel Trebicka, Christian P. Strassburg

    Almmustuhtton 2014
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Acute Decompensation and Acute-on-Chronic Liver Failure

    Acute Decompensation and Acute-on-Chronic Liver Failure Dahkki Philip G. Ferstl, Jonel Trebicka

    Almmustuhtton 2021
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Managing portal hypertension in patients with liver cirrhosis

    Managing portal hypertension in patients with liver cirrhosis Dahkki Tilman Sauerbruch, Robert Schierwagen, Jonel Trebicka

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Pré-impressão
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Gut-Liver Axis Links Portal Hypertension to Acute-on-Chronic Liver Failure

    Gut-Liver Axis Links Portal Hypertension to Acute-on-Chronic Liver Failure Dahkki Jonel Trebicka, Thomas Reiberger, Wim Laleman

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Acute and non‐acute decompensation of liver cirrhosis (47/130)

    Acute and non‐acute decompensation of liver cirrhosis (47/130) Dahkki Martin Schulz, Paolo Angeli, Jonel Trebicka

    Almmustuhtton 2024
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    The carbon tetrachloride model in mice

    The carbon tetrachloride model in mice Dahkki David Scholten, Jonel Trebicka, Christian Liedtke, Ralf Weiskirchen

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Shunt-Induced Hepatic Encephalopathy in TIPS: Current Approaches and Clinical Challenges

    Shunt-Induced Hepatic Encephalopathy in TIPS: Current Approaches and Clinical Challenges Dahkki Philipp Schindler, Hauke Heinzow, Jonel Trebicka, Moritz Wildgruber

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Bile Acids, Liver Cirrhosis, and Extrahepatic Vascular Dysfunction

    Bile Acids, Liver Cirrhosis, and Extrahepatic Vascular Dysfunction Dahkki Tilman Sauerbruch, Martin Hennenberg, Jonel Trebicka, Ulrich Beuers

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure

    Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure Dahkki Martin Schulz, Wen Gu, Andreas A. Schnitzbauer, Jonel Trebicka

    Almmustuhtton 2022
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    Liver Transplantation for Acute‐on‐Chronic Liver Failure: Science or Fiction?

    Liver Transplantation for Acute‐on‐Chronic Liver Failure: Science or Fiction? Dahkki Jonel Trebicka, Vinay Sundaram, Richard Moreau, Rajiv Jalan, Vicente Arroyo

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers

    Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers Dahkki Jonel Trebicka, Rubén Hernáez, Debbie L. Shawcross, Alexander L. Gerbes

    Almmustuhtton 2024
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Rationale for the use of statins in liver disease

    Rationale for the use of statins in liver disease Dahkki Robert Schierwagen, Frank Erhard Uschner, Fernando Magdaleno, Sabine Klein, Jonel Trebicka

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Statins: Old drugs as new therapy for liver diseases?

    Statins: Old drugs as new therapy for liver diseases? Dahkki Elisa Pose, Jonel Trebicka, Rajeshwar P. Mookerjee, Paolo Angeli, Pere Ginès

    Almmustuhtton 2018
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Communications via the Small Leucine-rich Proteoglycans: Molecular Specificity in Inflammation and Autoimmune Diseases

    Communications via the Small Leucine-rich Proteoglycans: Molecular Specificity in Inflammation and Autoimmune Diseases Dahkki Jinyang Zeng-Brouwers, Sony Pandey, Jonel Trebicka, Małgorzata Wygrecka, Liliana Schaefer

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    The microbiota in cirrhosis and its role in hepatic decompensation

    The microbiota in cirrhosis and its role in hepatic decompensation Dahkki Jonel Trebicka, Jane Macnaughtan, Bernd Schnabl, Debbie L. Shawcross, Jasmohan S. Bajaj

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Vascular dysfunction in human and rat cirrhosis: Role of receptor-desensitizing and calcium-sensitizing proteins

    Vascular dysfunction in human and rat cirrhosis: Role of receptor-desensitizing and calcium-sensitizing proteins Dahkki Martin Hennenberg, Jonel Trebicka, Erwin Biecker, Michael Schepke, Tilman Sauerbruch, Jörg Heller

    Almmustuhtton 2007
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    Systemic Inflammation and Acute-on-Chronic Liver Failure: Too Much, Not Enough

    Systemic Inflammation and Acute-on-Chronic Liver Failure: Too Much, Not Enough Dahkki Wim Laleman, J. J. Clariá, Van der Merwe, Richard Moreau, Jonel Trebicka

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    New clinical and pathophysiological perspectives defining the trajectory of cirrhosis

    New clinical and pathophysiological perspectives defining the trajectory of cirrhosis Dahkki Rajiv Jalan, Gennaro DʼAmico, Jonel Trebicka, Richard Moreau, Paolo Angeli, Vicente Arroyo

    Almmustuhtton 2021
    Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Extracellular Matrix Remodeling in Chronic Liver Disease

    Extracellular Matrix Remodeling in Chronic Liver Disease Dahkki Cristina Ortiz, Robert Schierwagen, Liliana Schaefer, Sabine Klein, Xavier Trepat, Jonel Trebicka

    Almmustuhtton 2021
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: